Johns Hopkins University School of Medicine, Baltimore, Maryland (C.W.H.).
Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (D.W., K.M., E.S.).
Ann Intern Med. 2021 Feb;174(2):167-174. doi: 10.7326/M20-1340. Epub 2020 Dec 8.
Growing evidence indicates that peripheral neuropathy (PN) is common even in the absence of diabetes However, the clinical sequelae of PN have not been quantified in the general population.
To assess the associations of PN with all-cause and cardiovascular mortality in the general adult population of the United States.
Prospective cohort study.
NHANES (National Health and Nutrition Examination Survey), 1999 to 2004.
7116 adults aged 40 years or older who had standardized monofilament testing for PN.
Cox regression to evaluate the associations of PN with all-cause and cardiovascular mortality after adjustment for demographic and cardiovascular risk factors, overall and stratified by diabetes status.
The overall prevalence of PN (±SE) was 13.5% ± 0.5% (27.0% ± 1.4% in adults with diabetes and 11.6% ± 0.5% in adults without diabetes). During a median follow-up of 13 years, 2128 participants died, including 488 of cardiovascular causes. Incidence rates (per 1000 person-years) of all-cause mortality were 57.6 (95% CI, 48.4 to 68.7) in adults with diabetes and PN, 34.3 (CI, 30.3 to 38.8) in adults with PN but no diabetes, 27.1 (CI, 23.4 to 31.5) in adults with diabetes but no PN, and 13.0 (CI, 12.1 to 14.0) in adults with no diabetes and no PN. In adjusted models, PN was significantly associated with all-cause mortality (hazard ratio [HR], 1.49 [CI, 1.15 to 1.94]) and cardiovascular mortality (HR, 1.66 [CI, 1.07 to 2.57]) in participants with diabetes. In those without diabetes, PN was significantly associated with all-cause mortality (HR, 1.31 [CI, 1.15 to 1.50]), but the association between PN and cardiovascular mortality was not statistically significant after adjustment (HR, 1.27 [CI, 0.98 to 1.66]).
Prevalent cardiovascular disease was self-reported, and PN was defined by monofilament testing only.
Peripheral neuropathy was common and was independently associated with mortality in the U.S. population, even in the absence of diabetes. These findings suggest that decreased sensation in the foot may be an underrecognized risk factor for death in the general population.
National Institute of Diabetes and Digestive and Kidney Diseases and National Heart, Lung, and Blood Institute of the National Institutes of Health.
越来越多的证据表明,周围神经病变(PN)在没有糖尿病的情况下也很常见。然而,PN 的临床后果在普通人群中尚未被量化。
评估 PN 与美国普通成年人群的全因和心血管死亡率的关系。
前瞻性队列研究。
NHANES(国家健康和营养检查调查),1999 年至 2004 年。
7116 名年龄在 40 岁或以上、接受 PN 单丝测试的成年人。
Cox 回归分析评估 PN 与全因和心血管死亡率的关系,调整人口统计学和心血管危险因素后,整体和按糖尿病状态分层。
PN 的总体患病率(±SE)为 13.5%±0.5%(糖尿病患者为 27.0%±1.4%,非糖尿病患者为 11.6%±0.5%)。在中位随访 13 年期间,有 2128 名参与者死亡,其中 488 名死于心血管原因。全因死亡率的发生率(每 1000 人年)在糖尿病合并 PN 的成年人中为 57.6(95%CI,48.4 至 68.7),在合并 PN 但无糖尿病的成年人中为 34.3(CI,30.3 至 38.8),在糖尿病但无 PN 的成年人中为 27.1(CI,23.4 至 31.5),在无糖尿病和无 PN 的成年人中为 13.0(CI,12.1 至 14.0)。在调整模型中,PN 与糖尿病患者的全因死亡率(危险比[HR],1.49[CI,1.15 至 1.94])和心血管死亡率(HR,1.66[CI,1.07 至 2.57])显著相关。在没有糖尿病的患者中,PN 与全因死亡率显著相关(HR,1.31[CI,1.15 至 1.50]),但 PN 与心血管死亡率之间的关联在调整后无统计学意义(HR,1.27[CI,0.98 至 1.66])。
先前存在的心血管疾病是自我报告的,并且仅通过单丝测试定义 PN。
周围神经病变在美国人群中很常见,与死亡率独立相关,即使在没有糖尿病的情况下也是如此。这些发现表明,足部感觉减退可能是普通人群死亡的一个未被充分认识的危险因素。
美国国立卫生研究院的国家糖尿病、消化和肾脏疾病研究所和国家心脏、肺和血液研究所。